Ivan Jose Suner MD MBA (He/Him)
Retinal Disease, Uveitis, Ocular Oncology
Managing Partner, Retina Associates of Florida, P.A.
Join to View Full Profile
602 S Macdill AvenueTampa, FL 33609
Phone+1 813-875-6373
Fax+1 813-876-0960
Dr. Suner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ivan Suner, MD, is an ophthalmologist based in Tampa, FL, specialized in retinal disease, uveitis, and ocular oncology. He completed his medical education at Yale School of Medicine and further training at Bascom Palmer Eye Institute. He holds an MBA in Health Care and Finance from the University of South Florida. Dr. Suner is currently the Managing Partner and Director of Clinical Research at Retina Associates of Florida. His previous academic roles include serving as an Associate and Assistant Professor of Ophthalmology at Duke University Hospital and the Bascom Palmer Eye Institute, respectively. He has published extensively on diabetic retinopathy, macular degeneration, and other retinal diseases, contributing significantly to clinical research. Dr. Suner has received multiple honors, including awards from the American Society of Retina Specialists and the American Academy of Ophthalmology.
Education & Training
University of South FloridaMBA, Business - Health Care and Finance, 2011 - 2014
Bascom Palmer Eye InstituteFellowship, 2000 - 2002
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1993 - 1996- Zucker School of Medicine at Hofstra/Northwell at Norwalk HospitalInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 1993 - 2028
NC State Medical License 2005 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NexTech with NewCropRx, NexTech Systems, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification NexTech Practice 2013, NexTech Systems, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification NexTech with NewCropRx, NexTech Systems, LLC, 2013, 2015-2017
Clinical Trials
- Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion Start of enrollment: 2008 Feb 01
- REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 2 citationsCoring of Intravitreal Medication Vial Stoppers: A Report From the Research in Safety and Therapeutics Committee of the American Society of Retina Specialists.Ferhina S Ali, Eric W Schneider, Sruthi Arepalli, Durga Borkar, Jordan D Deaner
Journal of Vitreoretinal Diseases. 2025-07-14 - 9 citationsDexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy.Ivan J. Suñer, Marc C. Peden
Clinical Ophthalmology. 2021-09-17 - 50 citationsBrolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study.Prashanth G. Iyer, Marc C. Peden, Ivan J. Suñer, Nish Patel, Sander R. Dubovy
American Journal of Ophthalmology Case Reports. 2020-11-10
Journal Articles
- Responsiveness of the NEI-VFQ-25 to Visual Acuity Gains in Patients with Diabetic Macular Edema: Evidence from the RIDE and RISE TrialsSuner IJ, Bressler NM, Varma R, Dolan CM, Ward J, Trupcu A, Retina, 1/1/2017
- Diabetic Retinopathy Clinical Research Network, Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranib...Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun J..., JAMA Ophthalmol, 1/1/2016
- Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving, in Patients with Diabetic Macular Edema: Report from RESTORE, RIDE, and RISE Tr...Bressler NM, Varma R, Mitchell P, Suner IJ, Dolan C, Ward J, Ferreira A, Ehrlich J, Turpcu A, JAMA Ophthalmol, 1/1/2016
Books/Book Chapters
Lectures
- Long-Term Continuous Treatment of Wet AMD with Anti-vascular Endothelial Growth Factor Agents (FIDO Study): 10-Year ResultsMykonos, Greece - 1/1/2017
- 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-Vascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration...Boston, MA - 1/1/2017
- Long-term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti-vascular Endothelial Growth Factor Agents in Wet Age-Related Macular Degeneration (FIDO Study)Paris, France - 1/1/2015
Other
- Measuring Quality of Life for Patients with Age-Related Macular Degeneration.Matchar DB, Suner IJ, Samsa GP, McCrory DC, Cline K, Lee PP, Agency for Healthcare Research and Quality
1/1/2006 - Influences of the lateral geniculate nucleus in the specification of primary visual cortex in Macaca mulatta.Suner IJ, Doctoral thesis
Yale University School of Medicine, New Haven, CT - 1/1/1992 - Studies in the purification of and the precocious induction of synthesis of juvenile hormone esterase in the tobacco hornworm, Manduca sexta.Suner IJ, Honors thesis for Bachelor of Arts Degree, Department of Biology
Harvard University, Cambridge, MA - 1/1/1988
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
